Calamos Advisors LLC Reduces Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Calamos Advisors LLC lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 20.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 505,591 shares of the pharmacy operator’s stock after selling 130,375 shares during the period. Calamos Advisors LLC’s holdings in Walgreens Boots Alliance were worth $39,593,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Meiji Yasuda Life Insurance Co grew its position in Walgreens Boots Alliance by 1.8% during the second quarter. Meiji Yasuda Life Insurance Co now owns 34,781 shares of the pharmacy operator’s stock worth $2,724,000 after buying an additional 600 shares in the last quarter. Northwestern Mutual Investment Management Company LLC grew its position in Walgreens Boots Alliance by 64.4% during the second quarter. Northwestern Mutual Investment Management Company LLC now owns 283,459 shares of the pharmacy operator’s stock worth $23,604,000 after buying an additional 111,085 shares in the last quarter. Northern Capital Management LLC grew its position in Walgreens Boots Alliance by 0.4% during the second quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock worth $520,000 after buying an additional 25 shares in the last quarter. Synovus Financial Corp grew its position in Walgreens Boots Alliance by 56.1% during the second quarter. Synovus Financial Corp now owns 16,697 shares of the pharmacy operator’s stock worth $1,313,000 after buying an additional 5,998 shares in the last quarter. Finally, Flagship Harbor Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 3.7% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 3,139 shares of the pharmacy operator’s stock valued at $242,000 after purchasing an additional 112 shares in the last quarter. Institutional investors own 63.79% of the company’s stock.

In other Walgreens Boots Alliance news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by insiders.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up $1.45 during trading on Friday, hitting $70.99. 12,380,900 shares of the stock traded hands, compared to its average volume of 5,343,083. The company has a market capitalization of $70,204.04, a PE ratio of 13.64, a P/E/G ratio of 1.24 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 52-week low of $63.82 and a 52-week high of $88.00. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. During the same quarter in the prior year, the firm posted $1.07 earnings per share. The business’s quarterly revenue was up 5.3% on a year-over-year basis. equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.

Walgreens Boots Alliance announced that its board has authorized a share buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Calamos Advisors LLC Reduces Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://stocknewstimes.com/2017/11/11/walgreens-boots-alliance-inc-wba-shares-sold-by-calamos-advisors-llc.html.

WBA has been the topic of several recent research reports. Needham & Company LLC set a $94.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Monday, July 17th. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. UBS AG reaffirmed a “buy” rating and set a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Loop Capital assumed coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a “buy” rating and a $95.00 target price for the company. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $87.63.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply